Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis Multiple sclerosis

Saved in:

Bibliographic Details
Published in:	Neurology Vol. 57; no. 12; pp. S25 - S30
Main Authors:	RUDICK, R. A, GOODKIN, D. E, ALAM, J. J, SIMONIAN, N. A, CAMPION, M. K, BARTOSZAK, D. M, BOURDETTE, D. N, BRAIMAN, J, BROWNSCHEIDLE, C. M, COATS, M. E, COHAN, S. L, DOUGHERTY, D. S, JACOBS, L. D, KINKEL, R. P, MASS, M. K, MUNSCHAUER, F. E, PRIORE, R. L, PULLICINO, P. M, SCHEROKMAN, B. J, WEISTOCK-GUTTMAN, B, WHITHAM, R. H, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GRANGER, C. V, SIMON, J. H
Format:	Journal Article
Language:	English
Published:	Hagerstown, MD Lippincott Williams & Wilkins 26-12-2001
Subjects:	Biological and medical sciences Immunomodulators Medical sciences Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Neurology Pharmacology. Drug treatments Human Nervous system diseases Chemotherapy Multiple sclerosis Interferon beta 2a Treatment Cytokine Central nervous system disease Interferon Recurrent Inflammatory disease Physical handicap
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0028-3878 1526-632X